DJIA 17,824.38 46.23 0.26%
NASDAQ 4,761.99 13.60 0.29%
S&P 500 2,066.79 5.56 0.27%
market minute promo

Biogen Idec (NASDAQ: BIIB)

355.51 1.81 (0.51%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIIB $355.08 0.39%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $343.28
Previous Close $353.70
Daily Range $343.06 - $359.76
52-Week Range $270.62 - $359.76
Market Cap $84.0B
P/E Ratio 33.49
Dividend (Yield) $0.00 (0.0%)
Volume 1,187,560
Average Daily Volume 1,778,578
Current FY EPS $13.47





Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website:

News & Commentary

3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc.

Pfizer is a staple in most retirement and income portfolios, but investors can find stronger growth prospects in each of these three big pharmaceutical stocks.

Biogen Idec (BIIB) Showing Signs Of Perilous Reversal Today

Bruker Unveils bioAFM System for High Resolution Imaging - Analyst Blog

Biogen Idec Poised To Continue Its Stellar Run

Watch For Today's Momo Momentum Stock: Biogen Idec (BIIB)

A 'Wisdom Of Experts' Portfolio

Insider Trading Alert - UGI, BIIB And CAMP Traded By Insiders

2015 Biotech Drug/Stock Outlook: Here's What You Need to Know

Gilead Sciences Stands Alone

Alkermes Starts Phase I Study on Schizophrenia Candidate - Analyst Blog

See More BIIB News...

BIIB's Top Competitors

BIIB $355.51 (0.51%)
Current stock: BIIB
AMGN $169.04 (0.33%)
Current stock: AMGN
GILD $106.84 (1.23%)
Current stock: GILD
$0.00 (0.00%)
Current stock: